CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 1 filers reported holding CONCERT PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $342,218 | -33.5% | 58,599 | -23.7% | 0.27% | -37.9% |
| Q3 2022 | $515,000 | +60.4% | 76,801 | +0.6% | 0.43% | +58.0% |
| Q2 2022 | $321,000 | +23.9% | 76,354 | -0.5% | 0.27% | +60.2% |
| Q1 2022 | $259,000 | -3.7% | 76,749 | -10.2% | 0.17% | +8.9% |
| Q4 2021 | $269,000 | -24.4% | 85,483 | +1.3% | 0.16% | -35.7% |
| Q2 2021 | $356,000 | -13.4% | 84,368 | +2.4% | 0.24% | -21.0% |
| Q1 2021 | $411,000 | -57.0% | 82,402 | +9.1% | 0.31% | -60.8% |
| Q4 2020 | $955,000 | – | 75,533 | – | 0.79% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| L1 Capital Pty Ltd | 1,149,120 | $14,559,000 | 2.72% |
| Corriente Advisors, LLC | 680,000 | $8,595,000 | 2.05% |
| ACUTA CAPITAL PARTNERS, LLC | 537,500 | $6,794,000 | 1.85% |
| INGALLS & SNYDER LLC | 1,362,203 | $17,218,000 | 0.85% |
| Kensington Investment Counsel, LLC | 75,533 | $955,000 | 0.79% |
| SPHERA FUNDS MANAGEMENT LTD. | 384,039 | $4,854,000 | 0.43% |
| Opaleye Management Inc. | 254,000 | $3,211,000 | 0.42% |
| RA Capital Management | 1,823,520 | $23,049,000 | 0.32% |
| Perceptive Advisors | 2,150,641 | $27,184,000 | 0.29% |
| Parkman Healthcare Partners LLC | 50,290 | $636,000 | 0.16% |